Please disable your adblock and script blockers to view this page

Lilly Alzheimer?s Drug Helped Patients in Small Trial


MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     14.00%   
   Negativity   86.00%
The New York Times
SOURCE: https://www.wsj.com/articles/lilly-alzheimers-drug-helped-patients-in-small-trial-11610364603?mod=hp_lead_pos4
Write a review: The Wall Street Journal
Summary

Donanemab slowed cognitive and functional decline of patients with mild Alzheimer?s by 32% compared with placebo

As said here by Jonathan D. Rockoff